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Abstract
Cholera toxin (CT) is a potent vaccine adjuvant, which promotes mucosal immunity to protein antigen given by nasal route.
It has been suggested that CT promotes T helper type 2 (Th2) response and suppresses Th1 response. We here report the
induction of Th17-dominated responses in mice by intranasal delivery of CT. This dramatic Th17-driving effect of CT, which
was dependent on the B subunit, was observed even in Th1 or Th2-favored conditions of respiratory virus infection. These
dominating Th17 responses resulted in the significant neutrophil accumulation in the lungs of mice given CT. Both in vitro
and in vivo treatment of CT induced strongly augmented IL-6 production, and Th17-driving ability of CT was completely
abolished in IL-6 knockout mice, indicating a role of this cytokine in the Th17-dominated T-cell responses by CT. These data
demonstrate a novel Th17-driving activity of CT, and help understand the mechanisms of CT adjuvanticity to demarcate T
helper responses.
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Introduction
Cholera toxin (CT), a major enterotoxin produced by Vibrio
cholerae, is a potent mucosal immunogen as well as adjuvant that
enhances mucosal and systemic antibody responses to codelivered
antigens [1]. Most studies have proposed that CT promotes a
strong Th2-dominant response to bystander antigens, based on the
production of IL-4, IL-5, and IL-10 but little IFN-c [2–5].
Furthermore, it has been also shown that CT and heat-labile
enterotoxin from Escherichia coli (LT) can suppress IL-12 and IFN-c
production [6,7]. However, other studies have reported mixed
Th1/Th2 response with the production of both IFN-c and IL-4
following oral and intranasal immunization with CT [8,9], and
Lavelle et al. demonstrated that CT also promotes the generation
of regulatory T cells against bystander antigens [10]. Thus, it
remains to be determined whether adjuvanticity of CT may
extend to the induction of other T-cell subsets such as recently
described IL-17-producing Th17 cells.
In this study, we examined the possibility that CT exerts any
regulatory effect on the differentiation of IL-17-producing CD4 T
cells in murine models. Here we demonstrate a novel ability of CT
that induces strong Th17-type responses against CT as well as
bystander antigens through intranasal delivery.
Results
Co-delivery of CT induces IL-17-producing CD4 T cells to
bystander antigen
To investigate whether CT has any regulatory activity on the
differentiation of Th17 cells, B6 mice were transferred with naı ¨ve
TCR-transgenic OT-II cells and then immunized once with
OVA323-339 peptide (ISQAVHAAHAEINEAGR; herein referred
to as OVAp II) together with CT intranasally. For comparison,
CpG oligodeoxynucleotide (ODN) was employed, which is well
known to promote T helper type 1 response [11]. At the peak
responses (day 7), ,7.9% and ,14.7% were Va2
+Vb5
+ donor
OT-II cells among CD4-gated cells in the lungs of OVAp
II+CT(0.2 mg) and OVAp II+CT(2 mg) group, respectively, while
,3.7% in the OVAp II+CpG group (Fig. 1A). The cytokine
profiles of CD4
+ T cells from the lungs of OVAp II+CT group
revealed significantly increased expression of IL-17 in response to
stimulation with OVAp II or PMA/ionomycin (P/I) with dose-
dependent manner, when compared to OVAp II or OVAp
II+CpG group (Fig. 1B). As a negative control, OVAp II alone
had no effect on the differentiation of Th cells. The average ratio
of IL-17:IFN-c-producing cells clearly indicates that OVA-
specific CD4 T cells were undergoing skewed differentiation
exclusively toward Th17 with co-delivery of CT (Fig. 1C). CT is
also one of the most powerful mucosal immunogens and the B
subunit of CT (CTB) contains an immunodominant CD4 T-cell
epitope, CTB89-100 peptide (NNKTPHAIAAIS; herein referred
to as CTBp), well-recognized by T cells of H-2
b background [12].
So, we checked CTBp-specific CD4 T-cell response in the lungs
of immune mice by intracellular cytokine staining, and found that
,1.3% and ,8.0% of gated CD4 T cells produce IL-17 upon
CTB peptide stimulation for OVAp II+CT(0.2 mg) and OVAp
II+CT(2 mg) group, respectively (Fig. 1D). The ratio of IL-
17:IFN-c-producing cells by CTB peptide stimulation was similar
to that by PMA/ionomycin stimulation. However, in this single
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production was detected ex vivo by ELISA or intracellular cytokine
staining in the lungs of either group of mice, nor any significantly
elevated Th17 response in the spleen and mediastinal lymph
nodes of OVAp II+CT group (data not shown). These results
clearly demonstrate that single intranasal co-delivery of CT
induces Th17-dominated T-cell responses to CT as well as
bystander antigen in the lungs.
To confirm whether the skewed differentiation of Th17 subset
by mucosal CT delivery also occurs in other settings of
immunization, we employed respiratory inoculation of recombi-
nant defective adenovirus expressing OVA protein (rAd/OVA).
We also made use of CTB instead of whole CT to see whether
Th17-inducing effect of CT resides in the B subunit. At day 14
after rAd immunization, the frequencies of CD8
+Tet
+ cells
infiltrating the lungs of rAd/OVA+CTB recipients were similar
to those of rAd/OVA group (,5.5% vs. ,5.0%), although the
absolute numbers of CD8
+Tet
+ cells were higher in rAd/
OVA+CTB group (,3610
5 vs. ,1.8610
5;F i g .2 A ) .W h e nt h e
CD4 T cells were stimulated with PMA/ionomycin and stained
for IL-17 and IFN-c, rAd/OVA+CTB group showed a
significantly increased ratio of IL-17:IFN-c-producing cells,
compared to rAd/OVA group (Fig. 2B and 2C). Consistent
with the previous results with peptide immunization shown in
Fig. 1, a similar ratio of IL-17:IFN-c-producing cells was also
observed upon stimulation with CTB peptide (Fig. 2D). To
exclude the possibility that Th17-driving activity of CTB is
mediated by contaminated CT A subunit in the CTB
preparation, 10 mg of purified recombinant CTA was used in
similar experiments and the results have shown that CTA has
little Th17-driving activity (Fig. 2E). Taken together, these
results strongly suggest that CT B subunit attributes to the
Th17-skewing activity of CT.
Recently, the existence of IL-17-secreting CD8 T-cell subset
(Tc17) was reported, which could be induced by TGF-b and IL-6
[13] or T-bet/Eomesodermin double knockout condition [14].
Thus, we checked whether IL-17-producing CD8 T-cell responses
were also induced by mucosal CTB delivery with rAd inoculation.
Although the frequency of IFN-c-positive cells was still higher than
that of IL-17-positive cells among CD8
+ T cells, IL-17 producers
were clearly increased in the lungs of rAd/OVA+CTB recipients
compared to rAd/OVA recipients (Fig. 2F), and the average ratio
of IL-17:IFN-c-producing CD8 T cells was also significantly
increased (Fig. 2G). These results indicate that CTB also influences
the differentiation of CD8 T cells and induces Tc17-type CD8 T-
cell responses.
Th17-driving ability of CT upon Th1 or Th2-favored
pulmonary RSV infection
B6 mice are generally predisposed to produce Th1-biased
responses to respiratory syncytial virus (RSV) infection [15] and
other pathogens [16,17]. To examine whether CT delivery still has
Th17-driving ability in the Th1-favored environment, we
employed RSV infection model in B6 mice and compared T-cell
responses in the presence or absence of CT. At the peak responses,
the percentages of IL-17-producing CD4 T cells in the lungs of
RSV+CT group were higher than RSV group (,6.9% vs. ,1.8%;
Fig. 3A), and the average ratio of IL-17:IFN-c-producing CD4 T
cells was also significantly increased (Fig. 3B). Consistent with the
previous results, ,1.3% was CTBp-specific among gated CD4 T
cells as judged by peptide stimulation (Fig. 3A).
We also examined the Th17-driving ability of CT upon RSV
infection in BALB/c mice, which are prone to develop Th2
rather than Th1. Similar to B6 mice, Th17-skewed responses
were observed upon pulmonary RSV infection in the presence of
CT (Fig. 3C and D). The total percentages of IL-17 and/or IFN-
c-producing CD4 T cells are generally higher in BALB/c mice
than B6 mice upon RSV infection. Together, these results clearly
demonstrate that even Th1 or Th2-prone response to respiratory
viral infection could be redirected to Th17-skewed one by CT
and Th17-driving ability of CT is independent of H-2
background.
CT induces neutrophil recruitment in the lung
Proinflammatory IL-17 is thought to promote inflammatory
responses by regulating production of chemokines and recruiting
neutrophils [18–20]. To test whether Th17 cells induced by CT
trigger airway infiltration of neutrophils, we examined neutro-
phil recruitment in the lung tissues of B6 mice with anti-Gr-1
staining at day 7 after peptide immunization. The neutrophils
represent the vast majority of Gr-1(Ly-6G)-positive cells in the
periphery, although Gr-1 is also expressed on some granulocytes
including eosinophils [21]. OVAp II+CT mice exhibited
excessive Gr-1
+ neutrophil infiltration in the lung airway,
compared with the OVAp II+CpG group (Fig. 4A). We also
examined the lungs of BALB/c mice infected with RSV+CT,
and consistently observed significantly increased numbers of Gr-
1
+ neutrophils compared to the RSV group (Fig. 4B). These
data suggest that Th17 response induced by CT delivery
promote recruitment of neutrophils possibly by regulating the
production of cytokines/chemokines and/or other cells involved
in neutrophil accumulation.
CT-induced IL-6 production, which is dependent on GM1
binding, is required for Th17-driving activity
The cytokines thought to be critical for promoting murine
Th17 differentiation are IL-6 and TGF-b [22–24]. The findings
that CT actively induces Th17 differentiation and airway
neutrophilia suggest that IL-6 and/or TGF-b could be involved
in the skewed Th17 differentiation by CT. We thus examined
whether the expression of IL-6 and/or TGF-b could be induced
by CT using bone marrow-derived dendritic cells in vitro, since
CT has been found to directly affect cytokine profiles of APC
[7,25]. Significantly increased IL-6 production was detected in
the DC cultures upon 24 h of CT treatment, and there was more
than 30-fold increase of IL-6 production during 72 h treatment
(Fig. 5A). However, we failed to detect any measurable TGF-b by
ELISA in the same culture supernatant (data not shown). In an in
vivo setting, significantly increased IL-6 production was also
observed in the lungs when bronchoalveolar lavage samples from
CT-treated B6 mice were examined (Fig. 5B). We also checked
the levels of TGF-b in the lungs, and intriguingly, constitutively
high levels of TGF-b (more than 500 pg/ml in the lung
homogenates) were detected by ELISA in mice during the
experimental periods (data not shown). These results strongly
suggest that induction of IL-6 mediates the ability of CT inducing
Th17-dominated responses. To determine whether endogenous
IL-6 production is necessary for the Th17-driving ability of CT,
IL-6 knockout (IL-6KO) mice were used for the experiment.
Compared to CT-treated wild type mice, IL-6KO mice are
almost completely resistant to the Th-17-driving effect of CT
(Fig. 5C, D), indicating that IL-6 induction is required for the
effect.
The previous results suggest that CT B subunit attribute to the
Th17-driving effect of CT (Fig. 2). To define the role of
ganglioside GM1 binding by CTB for the IL-6 induction and to
exclude the possible effect of LPS contamination, CT was pre-
incubated with 5-fold molar excess of GM1 and then added to DC
Th17-Dominated Responses by CT
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decreased the levels of IL-6 in the supernatant throughout the
culture period except for 24 h which was statistically not significant
(Fig. 5E). These results indicate that GM1 receptor binding of
CTB is important for the induction of IL-6 by CT. To further
exclude the possible influence of LPS contamination, CT was
heat-treated (100uC for 30 min) before administration into the
mice. Heat-inactivation of CT almost completely abolished the
induction of Th17 cells (Fig. 5F), suggesting that the observed
Th17-driving activity of CT was not due to endotoxin contam-
ination and the native conformation of CT is necessary for the
activity.
Discussion
In this study, we investigated the effect of CT on the
differentiation of IL-17-producing CD4 T cells in various in vivo
settings. CT is a powerful mucosal and/or parenteral adjuvant
which enhances cellular immune responses as well as mucosal IgA
and serum IgG responses to the coadministered antigens. Our
results clearly demonstrate that CT, through IL-6-dependent
pathway, facilitates the generation of Th17-type CD4 T cells.
Th17-type T cells, which produce IL-17, IL-17F, and IL-22, are
thought to be important for inflammatory responses and the
control of bacterial and fungal infections at mucosal surfaces
[26,27]. Previously, the requirement of IL-17 and IL-17-producing
T cells in host defense against extracellular pathogens have been
well demonstrated [28–30]. In addition, recent studies have shown
that IL-17A responses play an important role in naturally-acquired
immunity to pneumococcus in humans [31], and Th17-dependent
protection against pneumococcal challenge in mouse model [32].
Thus, this novel ability of CT to induce Th17-skewed responses
may certainly contribute to the immunological adjuvanticity of the
toxin and facilitate the development of efficacious vaccines against
respiratory bacterial infections.
IL-6 and TGF-b are essential cytokines for Th17 development
in vitro [22–24] and the orphan nuclear receptor RORct, which is
induced by IL-6 and TGF-b, is required for the expression of IL-
17 [33]. Although Th17 cells are shown to be involved in a
variety of autoimmune disease models in mice, their major role
might be a defense mechanism against extracellular bacteria and
fungi [34–36]. However, the conditions for the induction of Th17
cells by in vivo immunization have not been investigated yet.
Thus, our observation provides the evidence that antigen-specific
Th17 type responses could be actively induced with use of CT as
mucosal adjuvant. As IL-17-secreting T cells were shown to be a
key component of protective immunity to lung infections by
bacterial pathogens [37,38], this Th17-inducing activity of CT
adjuvant might be critical for certain bacterial vaccines. In
addition, we have shown that Th17-driving adjuvanticity of CT
resides in the B subunit. Although CT has the most potent
adjuvant activity, the use of this toxin in vaccination may pose
risks due to its innate toxicity. Thus, successful use of CT as
vaccine adjuvant in humans requires separation of toxicity from
adjuvanticity. In this regard, our results have significance for the
use of CTB as vaccine adjuvant in humans since non-toxic CT B
subunit is responsible for the CT’s ability to induce Th17-
dominated responses. Future studies will further determine the
effectiveness of antigen-specific Th17-type responses induced by
CT adjuvant for the protective immunity against various
pathogenic infections.
Recent studies have shown that oral immunization of CT
elicits Th2-biased responses, which in turn support the
development of high titer of IgG1, IgE, and mucosal IgA
[3,5]. Other studies also suggest that both Th1- and Th2-type
responses are involved in the induction of mucosal IgA responses
when CT is employed as mucosal adjuvant [8,39,40]. However,
these studies have not examined the presence of IL-17-producing
T cells as they preceded the identification of Th17 subset. Now,
we demonstrate that mucosal immunization with CT induces
Th17-dominating responses to bystander antigens as well as
CTB itself. The mechanism(s) of CT to promote the induction of
specific Th17 subsets is likely to involve direct influence on
APCs. We found that CT treatment of dendritic cells induces
strong IL-6 production, which was dependent on GM1 binding
of CT B subunit, and the in vivo Th17-driving ability of CT
requires endogenous IL-6 production (Fig. 5). These results are
consistent with the reports that CT induces IL-1 and IL-6
secretion by epithelial cells and APC [41,42]. Together, these
data suggest that CT can trigger the production of proin-
flammatory cytokines such as IL-6 by signaling through the
ganglioside GM1 receptor and subsequently induce the skewed
differentiation of Th17 cells. However, we have not completely
excluded the possibility that CTA translocated into the cell after
GM1 binding of CTB might be also involved in the IL-6
production.
In vitro treatment of BM-derived DC with CT was also shown to
induce full maturation as well as nuclear localization of NF-kBi n
DC in a GM1-dependent fashion [43], and up-regulated
production of cytokines such as IL-1b [44]. It has been reported
that TGF-b1 is constitutively expressed in the lungs and airway
epithelial cells activate latent TGF-b1 through binding of the
integrin avb6 which is up-regulated during pulmonary inflamma-
tion [45]. Consistent with this observation, constitutively high
amounts of TGF-b1 were detected by ELISA in the lungs of CT-
treated mice during the course of our experiments (data not
shown). Thus, it is likely that CT activates DCs and lung epithelial
cells through GM1-ganglioside binding to produce and activate
Th17-driving cytokines such as IL-6 and TGF-b, respectively,
which result in the skewed differentiation of Th17 cells during
antigenic stimulation.
In summary, we demonstrate that nasal immunization of CT
promotes the differentiation of Th17 cells directed to bystander
antigens, revealing a novel adjuvanticity of CT. Our data
presented here help understand the ability of CT to regulate T
helper demarcation and suggest the potential implication of CT
adjuvant for inducing desired types of immunity.
Materials and Methods
Mice and Ethics statement
Female C57BL/6 (B6) mice and BALB/c mice were purchased
from Charles River Laboratories (Yokohama, Japan). OT-II TCR
Figure 1. Co-delivery of CT induces IL-17-producing CD4 T cells to bystander peptide antigen. After transfer of OT-II splenocytes, the
recipient B6 mice were immunized once with 40 mg of OVAp II together with CpG (30 mg) or CT (0.2 mgo r2mg) intranasally. (A) Lung tissues were
isolated at day 7 and the frequencies of donor OT-II cells were measured by CD4, Va2 and Vb5 staining. (B) The lung mononuclear cells were
stimulated with OVAp II or PMA/ionomycin, or CTB peptide (D) and stained for CD4, IFN-c and IL-17. Only CD4
+ gated cells were shown in the dot
plots. (C) The graphs indicate the average ratio of IL-17:IFN-c expression of CD4
+ gated cells. Dot plots are representative of at least three
independent experiments and data are average 6 SEM, n=4,5 mice per group.
doi:10.1371/journal.pone.0005190.g001
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Jackson Laboratory (Bar Harbor, ME). Mice were housed under
specific pathogen-free conditions and were used between 5 and 8
weeks of age. All animals were handled in strict accordance with
good animal practice as defined by the relevant national and/or
local animal welfare bodies, and all animal work was approved by
Ewha Womans University’s institutional animal care and use
committee.
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CT and CTB were purchased from List Biological Laboratories
(Campbell, CA). For the recombinant CTA1, DNA encoding
cholera toxin A1 subunit (amino acid 1-194) was amplified by PCR
with the Vibrio cholerae (N16961 strain) DNA as a template, and
cloned into Xho I and BamH I sites of the pET15b-Tat-GFP-Tat
plasmid, resulting in pET15b-TCTA1T. The recombinant CTA1
was expressed and purified using Talon metal affinity column as
recommended by the manufacturer (Clontech, Palo Alto, CA).
Peptides were synthesized from Peptron Inc. (Daejon, Korea). CpG
ODN (TCCATGACGTTCCTGACGTT) with phosphorothioate
backbones was obtained from Bioneer Corp. (Daejon, Korea).
PMA and ionomycin were purchased from Sigma-Aldrich (St.
Louis, MO). Antibodies for flow cytometric analysis were from
BioLegend (San Diego, CA) and TCR-specific anti-Va2 (B20.1)
and Vb5 (MR9-4) were from BD Bioscience (San Diego, CA).
Figure 2. Intranasal CT co-delivery induces IL-17-producing CD4 T cells to bystander antigen expressed by recombinant
adenovirus. B6 mice were injected with the rAd/OVA together with PBS or 2 mg of CTB intranasally. At day 14 after immunization, lung tissues were
isolated and the frequencies of OVA-specific CD8 T cells were measured by anti-CD8 and OVA-Tet staining (A). The lung mononuclear cells were
stimulated with PMA/ionomycin (B), or CTB peptide (D) and stained for CD4, IFN-c and IL-17. CD4
+ gated cells were shown in the dot plots. (C) The
values of graph represent the average ratio of IL-17:IFN-c-producing CD4 cells. (E) B6 mice were injected with recombinant CTA (10 mg) or CTB (2 mg)
intranasally and at day 7 the lung mononuclear cells were stimulated with PMA/ionomycin. Only CD4
+ gated cells were shown. (F) The same lung cells
stimulated with PMA/ionomycin as in Fig. 2B were also stained for CD8, IFN-c and IL-17. CD8
+ gated cells were shown in the dot plots. (G) The graph
represents the average ratio of IL-17:IFN-c-producing CD8
+ cells. Dot plots are representative of at least two independent experiments and data are
average 6 SEM.
doi:10.1371/journal.pone.0005190.g002
Figure 3. Th17-driving ability of CT upon pulmonary RSV infection in B6 and BALB/c mice. (A) B6 mice were intranasally infected with live
RSV together with PBS or CT. At day 7 after infection, lung tissues were isolated, stimulated with PMA/ionomycin, and stained for CD4, IFN-c, and IL-
17. CD4
+ gated cells were shown in the dot plots. (B) The graph represents the average ratio of IL-17:IFN-c-producing CD4 cells. (C, D) The similar
experiments were performed in BALB/c mice. Dot plots are representative of at least two independent experiments and data are average 6 SEM,
n=4,5 mice per group.
doi:10.1371/journal.pone.0005190.g003
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Recombinant defective adenovirus expressing OVA (rAd/
OVA) was kindly provided by Y. C. Sung (Department of
Molecular and Life science, POSTECH). The rAd/OVA
stocks were propagated in 293 cells and titrated by TCID50.
RSV A2 strain was propagated in HEp-2 cells (ATCC,
Manassas, VA) in DMEM medium supplemented with 3%
heat-inactivated FCS, and titrated for infectivity by plaque
assay.
Immunization
For peptide immunization, 2610
6 OT-II splenocytes were
i.v. injected into B6 mice, and then recipient mice were i.n.
immunized with 40 mgo fO V Ap e p t i d ep l u s3 0mgo fC p G
ODN, 0.2 mg of CT, or 2 mgo fC To rC T Bi nP B S .F o rv i r u s
infection, mice were i.n. inoculated with 5610
6 PFU (for B6)
or 1610
6 PFU (for BALB/c) of RSV or 5610
7 PFU of rAd/
OVA.
Surface staining, intracellular staining, and flow
cytometric analysis
At appropriate time points, experimental mice were sacrificed,
and lung tissues, spleens, and mediastinal lymph nodes were
isolated. The lungs were perfused with 5 ml of PBS containing 10
U/ml heparin (Sigma-Aldrich) through the right ventricle. The
tissues were then processed through a steel screen to obtain single
cell suspension and particulate matter was removed by passing
through 70 mm Falcon cell strainers (BD Labware). Freshly
explanted cells were purified by density gradient centrifugation
and resuspended in FACS buffer (1 % FBS, 0.03 % sodium azide
in PBS) at a concentration of 1610
7 cells/ml. A total of 100 mlo f
these cells (1610
6 cells) was stained for CD8 (clone 53-6.7), CD4
(GK1.5), TCR Va2 (B20.1), Vb5 (MR9-4) or Gr-1(RB6-8C5) and
samples were acquired on FACSCalibur
TM (BD Biosciences). PE-
conjugated OVA-specific MHC I tetramer, OVA-Tet, was
produced as described elsewhere [46], and the optimal concen-
tration was determined by titration. Cells were stained for 40 min
at 4uC using fluorochrome-conjugate Abs and OVA-Tet, washed,
and fixed in PBS containing 2% formaldehyde before analysis by
flow cytometry. For intracellular staining, cells were stimulated
either with 10 mM peptide or PMA(50 ng/ml)/ionomycin(500 ng/
ml) for 5 h in the presence of Brefeldin A (10 mg/ml). The cells
were first stained for surface markers, washed, fixed and
permeabilized with FACS buffer containing 0.5% Saponin
(Sigma-Aldrich). Then, the cells were stained with anti-IFN-c
(XMG1.2), IL-17A (TC11-18H10.1), IL-4 (11B11) or IL-10 (JES5-
16E3). Gates were set on lymphocytes by forward and side scatter
profiles, and the data were analyzed using CellQuest
TM Pro (BD
Biosciences) and WinMDI version 2.9 software (The Scripps
Research Institute, La Jolla, CA).
Cytokine assays
Dendritic cells (DCs) were generated from bone marrow of B6
or BALB/c mice by culturing in complete RPMI medium
containing 10% FBS supplemented with 10 ng/ml recombinant
GM-CSF and IL-4 (R&D, Minneapolis, MN). After 7 days of
culture, non-adherent cells were harvested by gentle pipetting, and
DCs were enriched by density gradient centrifugation over Percoll
medium. After purification, DCs were further incubated with PBS
or CT (100 ng/ml) for 3 days and the culture supernatants were
harvested at the indicated time points. For blocking experiment,
the cholera toxin was pre-incubated with 5-fold molar excess of
GM1 ganglioside (10 ng/ml; Calbiochem, La Jolla, CA) for 30
min at 25uC before being added to the culture. The levels of
specific cytokines were determined by ELISA kits for IL-6 and
TGF-b (eBioscience) according to the manufacturer’s protocol.
Recombinant cytokine proteins were used as standards for
calculating cytokine concentrations in the culture supernatants.
The assays were carried out in triplicate wells.
Statistical analysis
Two-tailed Student’s t test was used for comparison of means,
and values of P,0.05 were considered statistically significant.
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Figure 4. CT induces neutrophil recruitment in the lungs. (A) B6
mice were given 40 mg of OVAp II peptide intranasally with 30 mgo f
CpG or 2 mg of CT. Lung tissues were isolated at day 7, and the number
of neutrophils was measured by Gr-1 staining and side scatter (SSC)
values. (B) BALB/c mice were inoculated with RSV in the presence or
absence of CT and the percentages of neutrophils are determined as in
(A). Data are obtained from two independent experiments and are
average 6 SEM, n=4,5 mice per group.
doi:10.1371/journal.pone.0005190.g004
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